Larimar Therapeutics, Inc. · NASDAQ:LRMR
Deerfield Management Company, L.P. reported a 34.41% stake in Larimar Therapeutics, Inc. (Schedule 13D/A)
Event Feb 27, 2026 · Filed Mar 2, 2026
Deerfield Management Company, L.P. reported a 34.41% stake in Larimar Therapeutics, Inc., 35,667,474 shares, with active intent on Feb 27, 2026. Filed Mar 2, 2026 (Schedule 13D/A).
- Stake
- 34.41%
- Shares
- 35,667,474
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deerfield Private Design Fund III, L.P. | 10.25% | 10,622,928 |
| Deerfield Healthcare Innovations Fund, L.P. | 7.87% | 8,153,107 |
| Deerfield Private Design Fund IV, L.P. | 10.25% | 10,622,957 |
| Deerfield Partners, L.P. | 5.99% | 6,207,982 |
| Deerfield Mgmt III, L.P. | 10.25% | 10,622,928 |
| Deerfield Mgmt HIF, L.P. | 7.87% | 8,153,107 |
| Deerfield Mgmt IV, L.P. | 10.25% | 10,622,957 |
| Deerfield Mgmt, L.P. | 5.99% | 6,207,982 |
| Deerfield Management Company, L.P. | 34.41% | 35,667,474 |
| James E. Flynn | 34.41% | 35,667,474 |
Source
Related
- Larimar Therapeutics, Inc.
- Deerfield Management Company, L.P.
- Larimar Therapeutics, Inc. shareholders
- Schedule 13D/A · Deerfield Management Company, L.P. · Jul 31, 2025
- Form 4 · Harlow John B. Jr. · Oct 1, 2026
- Form 4 · Hamilton Thomas Edward · Jul 8, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · May 14, 2026
- Schedule 13G/A · Millennium Management LLC · Apr 30, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Feb 17, 2026